Innovating products with cutting-edge research
Pear Therapeutics conducts ongoing clinical trials to develop and evaluate innovative products across many indications.
Thank you for your interest. The DREAM Study has reached its enrollment limit and the study is closed to new participants.
If you are looking for resources to help you with chronic insomnia, we have provided a list of optional resources below. If you are interested in the prescription digital therapeutic used in the DREAM trial, it is now available by prescription. You can learn more about it here.
American Academy of Sleep Medicine – Sleep Team
American Sleep Association – Insomnia Symptoms, Causes, and Treatment
Mayo Clinic Insomnia Overview
National Institutes of Health – Insomnia
National Sleep Foundation
Society of Behavioral Sleep Medicine
OPIOID USE DISORDER STUDY
Pear Therapeutics is currently registering participants for a study to test a new investigational digital therapy for people with opioid use disorder (OUD). The digital therapy delivers behavioral therapy lessons that teach skills, such as how to refuse drugs if they are offered to you and how to manage cravings or the desire to use. If you have a smartphone and would like to see if you are eligible for the study, please click here to complete a short form. If you are eligible, our study team will contact you about screening.
The Opioid Use Disorder Study is registered with the National Institutes of Health on clinicaltrials.gov and can be viewed here.